Physician profile
Michael Perez Rodriguez
NPI 1376915330
$6,019.77
in general payments reported to CMS, 2019-2025
14 companies · $4,656 in 2025
The $4,656 reported for 2025 was more than what 97% of Adult Medicine providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $832 · 2024: $532 · 2025: $4,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,202 · Food and Beverage: $1,877 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,201.70 |
| Food and Beverage | $1,877.27 |
| Education | $109.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,655.52 | 2025 | Watchman Access System |
| Amgen INC. | $1,442.55 | 2024-2025 | Repatha |
| Abbott Laboratories | $1,149.66 | 2025 | Cardiomems |
| Intuitive Surgical, INC. | $831.58 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $255.97 | 2024 | Opsumit, Uptravi |
| Alnylam Pharmaceuticals INC. | $139.77 | 2025 | Onpattro |
| Astrazeneca Pharmaceuticals Lp | $124.88 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.07 | 2025 | |
| Daxor Corporation | $109.89 | 2024 | Bva-100 |
| Bridgebio Pharma, INC. | $88.62 | 2025 | Attruby |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.77 | 2024-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $20.22 | 2025 | |
| Heartflow, INC. | $19.95 | 2024 | |
| United Therapeutics Corporation | $16.32 | 2024 | Tyvaso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Perez Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.